N2Q-11038-37208
1 vaccination
2 coded responses
6 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 683 / NE
- Registered
- 2020-12-24
- Relationship
- Self
Timeline
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2020-12-24
Registered in v-safe
- 2020-12-26
-
2020-12-27
Survey response — days 1–6 daily, dose 1MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: Congestion, runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-28
Survey response — days 1–6 daily, dose 1MedDRA: Respiratory tract congestion — Feeling: FairFree text: CongestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-29
- 2020-12-30
- 2021-01-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Congestion, runny nose
Systemic reaction (other): Congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release